From RE-LY to RE-DUAL PCI: a decade of innovation

2 September 2019 (13:00 - 13:05)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Christopher Paul Cannon

Brigham and Women's Hospital, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail

Antithrombotic therapy post-PCI: is your practice keeping up with the guidelines?

Professor D. Angiolillo (Jacksonville, US)

Presentation thumbnail

Antithrombotic therapy post-PCI: practical tips for challenging scenarios

Professor J. ten Berg (Nieuwegein, NL)

Presentation thumbnail

Cardioversion, ablation, and devices: practical tips to treat your atrial fibrillation patients

Professor D. Gupta (Liverpool, GB)

Presentation thumbnail

Panel discussion and questions and answers: NOACs in cardiac patients undergoing procedures

Professor D. Angiolillo (Jacksonville, US) Professor C. Cannon (Boston, US)

Access the full session

Session thumbnail

NOACs in patients undergoing cardiac procedures

The Event

ESC Congress 2019

2 September 2019 13:00 CET

You may be interested in

Congress Session

Breaking boundaries in PCI: how is the SELUTION DeNovo trial impacting your PCI practice?

19 February 2026

Congress Presentation

RKER-012, a novel modified ActRIIB ligand trap, attenuated right ventricular cardiomyopathy in a preclinical model of pulmonary arterial hypertension.

31 August 2024

Congress Presentation

The novel subcutaneously administered glycoprotein IIb/IIIa antagonist RUC-4 (Zalunfiban) did not cause thrombocytopenia in the phase 2a study of patients with ST-elevation myocardial infarction

18 March 2022

Congress Presentation

Computer assisted vacuum thrombectomy: evidence and emerging data

28 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources